Detalhe da pesquisa
1.
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Br J Cancer
; 127(11): 2034-2042, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175621
2.
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Oncologist
; 27(2): 87-e115, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641222
3.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747948
4.
Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
BMC Cancer
; 19(1): 620, 2019 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234810
5.
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
BMC Cancer
; 19(1): 517, 2019 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31146717
6.
Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer.
Am J Otolaryngol
; 36(2): 268-72, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681954
7.
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years.
Int J Cancer
; 132(2): E58-65, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915138
8.
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades.
Arch Gynecol Obstet
; 288(6): 1203-12, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190694
9.
Surgical margins in head and neck squamous cell carcinoma: what is 'close'?
Eur Arch Otorhinolaryngol
; 270(10): 2603-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23271033
10.
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.
BJU Int
; 110(5): 692-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22364110
11.
Achievements and unmet needs in the management of advanced ovarian cancer.
Gynecol Oncol
; 117(2): 152-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20056266
12.
A computational workflow for the design of irreversible inhibitors of protein kinases.
J Comput Aided Mol Des
; 24(3): 183-94, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20306284
13.
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy.
JCO Oncol Pract
; 16(2): e211-e220, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31855497
14.
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer.
Transl Lung Cancer Res
; 9(5): 1810-1821, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33209603
15.
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis.
Cancer Treat Rev
; 84: 101965, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32000054
16.
Weekly low-dose paclitaxel as maintenance treatment in patients with advanced ovarian cancer who had microscopic residual disease at second-look surgery after 6 cycles of paclitaxel/platinum-based chemotherapy: results of an open noncomparative phase 2 multicenter Italian study (After-6 Protocol 2).
Int J Gynecol Cancer
; 19(4): 615-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19509559
17.
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).
Clin Breast Cancer
; 8(1): 97-100, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18501066
18.
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus.
Biomed Res Int
; 2018: 3756981, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30140695
19.
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.
Cancer Biol Ther
; 19(10): 879-886, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30067438
20.
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Int J Radiat Oncol Biol Phys
; 68(5): 1455-61, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17445998